India
· Delayed Price · Currency is INR Senores Pharmaceuticals Statistics
Total Valuation
BOM:544319 has a market cap or net worth of INR 23.37 billion. The enterprise value is 22.93 billion.
| Market Cap | 23.37B |
| Enterprise Value | 22.93B |
Important Dates
The last earnings date was Thursday, May 15, 2025.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 46.05M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +562.54% |
| Shares Change (QoQ) | +37.29% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 19.36M |
Valuation Ratios
The trailing PE ratio is 39.91 and the forward PE ratio is 18.61.
| PE Ratio | 39.91 |
| Forward PE | 18.61 |
| PS Ratio | 5.60 |
| PB Ratio | 2.88 |
| P/TBV Ratio | 4.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.04, with an EV/FCF ratio of -11.27.
| EV / Earnings | 39.15 |
| EV / Sales | 5.49 |
| EV / EBITDA | 21.04 |
| EV / EBIT | 24.89 |
| EV / FCF | -11.27 |
Financial Position
The company has a current ratio of 3.00, with a Debt / Equity ratio of 0.39.
| Current Ratio | 3.00 |
| Quick Ratio | 2.12 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 2.89 |
| Debt / FCF | -1.55 |
| Interest Coverage | 4.27 |
Financial Efficiency
Return on equity (ROE) is 11.18% and return on invested capital (ROIC) is 7.12%.
| Return on Equity (ROE) | 11.18% |
| Return on Assets (ROA) | 6.23% |
| Return on Invested Capital (ROIC) | 7.12% |
| Return on Capital Employed (ROCE) | 9.34% |
| Revenue Per Employee | 28.79M |
| Profits Per Employee | 4.04M |
| Employee Count | 113 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 3.84 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 543.51 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 45.91 |
| Average Volume (20 Days) | 30,402 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544319 had revenue of INR 4.18 billion and earned 585.60 million in profits. Earnings per share was 16.12.
| Revenue | 4.18B |
| Gross Profit | 2.37B |
| Operating Income | 921.20M |
| Pretax Income | 705.70M |
| Net Income | 585.60M |
| EBITDA | 1.09B |
| EBIT | 921.20M |
| Earnings Per Share (EPS) | 16.12 |
Balance Sheet
The company has 3.86 billion in cash and 3.15 billion in debt, giving a net cash position of 707.50 million.
| Cash & Cash Equivalents | 3.86B |
| Total Debt | 3.15B |
| Net Cash | 707.50M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 8.12B |
| Book Value Per Share | 168.00 |
| Working Capital | 4.82B |
Cash Flow
In the last 12 months, operating cash flow was -459.20 million and capital expenditures -1.58 billion, giving a free cash flow of -2.03 billion.
| Operating Cash Flow | -459.20M |
| Capital Expenditures | -1.58B |
| Free Cash Flow | -2.03B |
| FCF Per Share | n/a |
Margins
Gross margin is 56.72%, with operating and profit margins of 22.06% and 14.03%.
| Gross Margin | 56.72% |
| Operating Margin | 22.06% |
| Pretax Margin | 16.90% |
| Profit Margin | 14.03% |
| EBITDA Margin | 26.10% |
| EBIT Margin | 22.06% |
| FCF Margin | n/a |
Dividends & Yields
BOM:544319 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -562.54% |
| Shareholder Yield | n/a |
| Earnings Yield | 2.51% |
| FCF Yield | -8.70% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |